ECM
BDSX icon

Endurant Capital Management’s Biodesix BDSX Stock Holding History

Endurant Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,663
Closed -$211K – 39
2023
Q1 		$211K Sell
5,663
-559
-9% -$22.9K 0.11% 47
2022
Q4 		$286K Sell
6,222
-285
-4% -$7.75K 0.12% 52
2022
Q3 		$165K Sell
6,507
-31
-0.5% -$1.2K 0.05% 48
2022
Q2 		$214K Hold
6,538
– – 0.08% 48
2022
Q1 		$221K Buy
+6,538
New +$427K 0.06% 63

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Endurant Capital Management's BDSX Position: Q2 2023 in Review

Endurant Capital Management sold out of Biodesix (BDSX) in Q2 2023, closing a stake of 5,663 shares — an estimated $211K sold.

Endurant Capital Management first reported a position in BDSX in Q1 2022 and held it in 5 quarters. The position peaked at $286K in Q4 2022. 29 funds tracked by Wall St. Rank hold BDSX as of Q2 2023.

  • Endurant Capital Management reported no remaining Biodesix position as of Q2 2023 after selling out during the quarter.
  • Endurant Capital Management sold 5,663 Biodesix shares in Q2 2023, an estimated $211K.
  • Endurant Capital Management first reported a position in Biodesix in Q1 2022 and held it in 5 quarters.
  • Endurant Capital Management's Biodesix position peaked at $286K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Biodesix as of Q2 2023.

Based on Endurant Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.